Profrssor Wu is vice director of Fudan University Shanghai Cancer Center, Chairman of Chinese Anti-Cancer Association, Committee of Breast Cancer Society, and vice Chairman of Chinese Medical Association, Branch of Oncology & Branch of Surgery, the Committee of the Division of Surgical Operation, also as vice Chairman of Chinese Medical Doctor Association, Branch of Oncologist. His research interest is gene signature in breast cancer prognosis and prediction. As a breast surgeon, Professor Wu focuses on breast cancer conservative surgery, sentinel lymph node biopsy and onco-plastic surgery involving immediate breast reconstruction, partial breast reconstruction. He has research funding from National Natural Science Foundation of China (NSFC), Ministry of Science and Technology and Shanghai Health Bureau et al, with more than 100 publications in peer-reviewed International or Chinese core journals. He has been an invited speaker at many national meetings, and expert panels on breast cancer management.

• Jul 1987-Jun 1993

  M.B study: Shanghai Medical University

• Jul 1993-Jun 1998

  M.D. study: Shanghai Medical University

• 202104- present: Chairman, Chinese Anti-Cancer Association, Committee of Breast Cancer Society

• 201907- present: Vice Chairman, Chinese Medical Association, Branch of Surgery, the Committee of the Division of Surgical Operation

• 201904- present: Vice Chairman, Chinese Medical Association, Branch of Oncology

• 201904- present: Vice Chairman, Chinese Medical Doctor Association, Branch of Oncologist

• 201903- present: Standing Director, The 8th Council of Shanghai Anti Cancer Association

• 202104- present: Appointed Chairman Shanghai Medical Association, Branch of Oncology

• 201910- present: Honorary Chairman, Shanghai Anti Cancer Association, Committee of Breast Cancer Society

• 201610- 202010: Former Chairman, Shanghai Medical Association, Committee of Tumor Target Molecule Society

1. Rong Guo, Yonghui Su, Qi Zhang, Bingqiu Xiu, Sheng Huang, Weiru Chi, Liyi Zhang, Lun Li, Jianjing Hou, Jia Wang, Jiajian Chen, Yayun Chi*, Jingyan Xue*, Jiong Wu*. LINC00478-derived novel cytoplasmic lncRNA LacRNA stabilizes PHB2 and suppresses breast cancer metastasis via repressing MYC targets. Journal of Translational Medicine. 2023, 21(1):120.

2. Qi Zhang, Bingqiu Xiu, Liyi Zhang, Ming Chen, Weiru Chi, Lun Li, Rong Guo, Jingyan Xue, Benlong Yang, Xiaoyan Huang, Zhi-Ming Shao, Shenglin Huang, Yayun Chi*,Jiong Wu*, Immunosuppressive lncRNA LINC00624 promotes tumor progression and therapy resistance through ADAR1 stabilization. Journal for ImmunoTherapy of Cancer. 2022, 10(10): e004666.

3. Pei Li, Lun Li, Bingqiu Xiu, Liyi Zhang, Benlong Yang, Yayun Chi, Jingyan Xue*, Jiong Wu*. The Prognoses of Young Women With Breast Cancer (≤35 years) With Different Surgical Options: A Propensity Score Matching Retrospective Cohort Study. Frontiers in Oncology. 2022, 12(795023).

4. Yonghui Su, Yuchen Li, Rong Guo, Jingjing Zhao, Weiru Chi, Hongyan Lai, Jia Wang, Zhen Wang, Lun Li, Yuting Sang, Jianjing Hou, Jingyan Xue, Zhimin Shao, Yayun Chi*, Shenglin Huang*, Jiong Wu*. Plasma extracellular vesicle long RNA profiles in the diagnosis and prediction of treatment response for breast cancer, NPJ Breast Cancer. 2021, 7(1): 0-154.

5. Jia Wang, Bingqiu Xiu, Rong Guo, Qi Zhang, Yonghui Su, Lun Li, Weiru Chi, Zhimin Shao, Jiong Wu*. Autologous tissue reconstruction after mastectomy-A cross-sectional survey of 110 hospitals in China. European Journal of Surgical Oncology. 2020, 46(12):2202-2207.

6. Benlong Yang, Guosheng Ren, Erwei Song, Da Pan, Jing Zhang, Yongsheng Wang, Ning Liao, Jinhai Tang, Xiang Wang, Shude Cui, Feng Jin, Cuizhi Geng, Qiang Sun, Hongyuan Li, Zhimin Fan, Xuchen Cao, Haibo Wang, Shu Wang, Zhimin Shao, Jiong Wu*. Current Status and Factors Influencing Surgical Options for Breast Cancer in China: A Nationwide Cross-Sectional Survey of 110 Hospitals. Oncologist. 2020, 25(10):e1473-e1480.

7. Rong Guo, Yonghui Su, Jing Si, Jingyan Xue, Benlong Yang, Qi Zhang, Weiru Chi, Jiajian Chen, Yayun Chi, Zhimin Shao, Jiong Wu*. A Nomogram for Predicting Axillary Pathologic Complete Response in Hormone Receptor–Positive Breast Cancer with Cytologically Proven Axillary Lymph Node Metastases. Cancer. 2020, 126:3819-3829.

8. Yayun Chi, Jingyan Xue, Sheng Huang, Bingqiu Xiu, Yonghui Su, Wei Wang, Rong Guo, Lei Wang, Lun Li, Zhimin Shao, Wei Jin, Zhaohui Wu*, Jiong Wu*. CapG promotes resistance to paclitaxel in breast cancer through transactivation of PIK3R1/P50, Theranostics. 2019, 9(23): 6840-6855.

9. Bingqiu Xiu, Yayun Chi, Lei Liu, Weiru Chi, Qi Zhang, Jiajian Chen, Rong Guo, Jing Si, Lun Li, Jingyan Xue, Zhi-Ming Shao, Zhao-Hui Wu*, Shenglin Huang*, Jiong Wu*. LINC02273 drives breast cancer metastasis by epigenetically increasing AGR2 transcription. Molecular Cancer. 2019, 18(1): 0-187.

10. Yonghui Su, Rong Guo, Jingyan Xue, Yayun Chi, Weiru Chi, Jia Wang, Benglong Yang, Jiong Wu*. Increased Mortality with Repeat Lumpectomy Alone After Ipsilateral Breast Tumor Recurrence. Oncologist. 2019, 24(9):e818-e827.